About the Editors
Editors-in-Chief
Mohamad Mohty, MD, PhD, Sorbonne University, Paris, France
Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty is also head of a translational research team (INSERM) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of immunomodulatory agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty serves as Scientific Council Chair of the European Society for Blood and Marrow Transplantation (EBMT) and the âIntergroupe Francophone du Myelomeâ (IFM).
Bipin Savani, MD, Vanderbilt University Medical Center, United States of America
Dr Savaniâs area of specialization is in the treatment of hematological malignancies, stem cell transplantation/ cellular therapy, and his primary field of research is in the long-term follow-up after transplantation/ cellular therapy, including regimen-related toxicity/ supportive care, and outcomes analysis of hematological malignancies, transplant and cellular therapy recipients. Dr Savani has published over 500 peer-reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological malignancies, stem cell transplantation and cellular therapy. Dr Savani is currently leader of the Conditioning Regimen Subcommittee of the Acute Leukemia Working Party of the EBMT. He also serves as Co-Chair Regimen-Related Toxicity and Supportive Care-CIBMTR and medical monitor for Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). Dr Savani is a member of the ASH Committee on Practice (COP) and a liaison member from the COP to the ASH Task Force on Immunotherapies subcommittee. He has recently edited several special issues for Seminars in Hematology, Hematology/ Oncology Clinics of North America and edited Wiley books entitled "Blood and Marrow Transplantation Long Term Management: Prevention and Complications" (first ed 2014, second ed May 2021) and "Clinical guide to transplantation in lymphomas" (first ed 2015). Co-authored handbook on Leukemia (FAST FACTS: Leukemia, first ed 2019). He has served as a Foundation for the Accreditation of Cellular Therapy (FACT) adults program clinical/ marrow collection facilities and Immune Effector Cell (IEC) inspector role since 2011.
Executive Editor
Jakob R Passweg, MD, MS, Basel University Hospital, Switzerland
BMT Ambassadors
Jane F Apperley, MBChB, MD, FRCP, FRCPath, FMedSci, Imperial College London, United Kingdom
Robert Peter Gale, MD, PhD, DSc(hc), FACP, FRCP, FRCP(I), FRSM, Imperial College London, United Kingdom
Armand Keating, MD, FRCPC, University of Toronto, Canada
Alejandro Madrigal, OBE FMedSci, MD, PhD, FRCP, FRCPath, DSc, HonDSci, UCL Cancer Institute, United Kingdom
Yair Reisner, PhD, Weizmann Institute of Science, Israel
Associate Editors
Veronika Bachanova, MD, PhD, University of Minnesota, United States of America
Karen Ballen, MD, University of Virginia Cancer Center, United States of America
Ali Bazarbachi, MD, PhD, American University of Beirut, Lebanon
Didier Blaise, MD, Aix Marseille University, France
Jaap Jan Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, United States of America
Ronjon Chakraverty, MBChB, MRCP, FRCPath, PhD, University of Oxford, United Kingdom
Selim Corbacioglu, MD, PhD, University Medical Center of Regensburg, Germany
Peter Dreger, MD, University of Heidelberg, Germany
Nada Hamad, BSc, MSc Forensic (hons), MBBS (hons), FRACP, FRCPA SpeCetClinRes (Onc), FRCP AFRACMA, St Vincents Hospital Sydney, Australia
Ernst Holler, MD, PhD, University Hospital Regensburg, Germany
Myriam Labopin, MD, MS, Sorbonne University, France
Per Ljungman, MD, PhD, Karolinska Institutet, Sweden
Florent Malard, MD, PhD, Sorbonne University, France
Arnon Nagler, MD, MSc, Chaim Sheba Medical Center, Israel
Miguel-Angel Perales, MD, Memorial Sloan Kettering Cancer Center, United States of America
Bart Scott, MD, Fred Hutchinson Cancer Center, United States of America
Lynne Strasfeld, MD, Oregon Health and Science University, United States of America
Social Media Editor
Florent Malard, MD, PhD, Sorbonne University, France
Florent Malard is Associate Professor of Hematology at the Saint-Antoine Hospital and Sorbonne University. He is also a researcher at the Saint-Antoine research Center in Paris and his research focus on Graft-versus-Host disease, microbiota and immunological complication of allogeneic hematopoietic stem cell transplantation. He is leading the microbiota working group within the Cellular Therapy and Immunotherapy Working Party of The EBMT. He has published more than 60 papers in peer-reviewed journals.